Hospitals are seeing more patients ask specifically for blood from donors who haven’t had COVID-19 vaccines, a trend that can slow care and create risks; this article examines why those requests happen, how hospitals respond, the safety evidence around vaccinated donors, and expert recommendations for handling these situations.
Requests for so-called unvaccinated blood have landed in transfusion services across the country, and clinicians say they can be disruptive. Families sometimes insist on direct donations from relatives to meet those demands, which sounds comforting but isn’t always safer. The rise in requests followed the rollout of COVID-19 vaccines and has become a recurring operational headache.
There is no reliable way to tag donated blood as coming from a vaccinated or unvaccinated person, and blood centers do not routinely record vaccination status. Scientific review and transfusion experts have found no evidence that blood from vaccinated donors poses a unique risk to recipients. Still, strong patient preferences are translating into special orders that complicate hospital workflows and supply management.
Directed donations, where a relative gives blood specifically for one patient, are common when families want to control the source. However, those donations often come from first-time donors and carry higher rates of undetected infections or problems on the first screen. “Despite being framed as ‘safer,’ directed donations may paradoxically increase risk.”
When standard blood is refused, clinical consequences can be serious. In some cases patients have deteriorated because transfusions were delayed while staff hunted for alternative units. “These requests were associated with care delays, escalation and inefficiencies,” which captures the frustration clinicians feel when logistics trump timely care.
Researchers and professional organizations have pushed back against policies that would segregate blood by donor vaccination history. “Regulatory and professional organizations have opposed these non-evidence-based policies, emphasizing that blood centers do not record or convey donor COVID-19 vaccination status and that evidence demonstrates transfusion from vaccinated donors poses no unique risk.” That consensus shapes current guidance.
Any study looking at these incidents has limits, and much of the data come from individual hospital reports rather than large trials. Observational accounts can show associations but not prove causation between refusal of standard blood and specific outcomes. Still, the ethical and practical issues are clear when clinical teams must balance respect for preferences with the duty to provide safe, timely treatment.
Some states have considered bills to create special reserves of unvaccinated-donor blood or to require hospitals to honor those requests, but so far none of the proposals have become law. When families press for direct donations, clinicians urge a careful, documented process because “Blood has to be prescribed. You can’t just show up at the blood center and say, ‘I would like my sister to donate for me,’” she said. “There needs to be a prescription. It needs to go through the hospital … they need to make sure it is the right blood for the right patient.”
Transfusion medicine specialists are the best resource to answer specific concerns, and hospitals recommend early conversations when a transfusion may be needed. “These are physicians who have a specialty in blood transfusions … and who can answer those questions that any individual will have.” Timely consultation can prevent harmful delays and ensure appropriate screening and matching.
Ultimately, blood availability depends on donors showing up, not their vaccination status, and blood centers continue to urge broad participation. “We need people – vaccinated or not vaccinated – to show up and donate blood, because it is the blood on the shelves that saves lives.” The practical message for communities is straightforward: anyone who can safely donate should consider doing so to keep supplies ready for emergencies.
